RxDoctor Payments DataLook up a doctor →

Kirby Cox, NP

Family · Shreveport, LANPI 1174168462

Payments from drug & device makers

$14,100in general payments, 2019–2025

Across 457 payments — averaging $30.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$4K
  • AbbVie$2K
  • UCB, Inc.$1K
  • SK Life Science, Inc.$737
  • Neurelis, Inc.$601
  • EMD Serono, Inc.$490
  • plus $6K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Livanova USA, Inc.13$3,642
AbbVie(2 entities)135$1,518
UCB, Inc.38$1,013
SK Life Science, Inc.27$737
Neurelis, Inc.15$601
EMD Serono, Inc.21$490
Neurocrine Biosciences, Inc.17$449
AstraZeneca18$418
Novartis23$413
Abbott3$392
Biogen17$379
Amgen13$276
Genentech USA, Inc.13$259
Regeneron Healthcare Solutions, Inc.2$250
Argenx US, Inc.10$191
Lundbeck LLC9$171
Biohaven Pharmaceuticals, Inc.7$164
GSK2$156
Hologic Sales And Service, LLC1$150
Dexcom, Inc.1$130
Insulet Corporation1$127
Ardelyx, Inc.1$125
Phathom Pharmaceuticals, Inc.1$125
Itamar Medical Inc1$125
Corcept Therapeutics1$125
Kyowa Kirin, Inc.1$125
Gilead1$120
Sumitomo Pharma America, Inc.6$109
Tanabe Pharma America, Inc.6$104
Merz Pharmaceuticals, LLC5$104
Eisai Inc.5$101
Pfizer6$91
Upsher-smith Laboratories LLC2$87
Inspire Medical Systems, Inc.1$82
Novo Nordisk1$71
Amylyx Pharmaceuticals, Inc.3$62
Mallinckrodt Hospital Products Inc.3$59
Medtronic1$57
Edwards Lifesciences1$55
Teva Pharmaceuticals USA, Inc.3$53
ANI Pharmaceuticals, Inc.3$47
Biohaven Pharmaceutical Holding Company Ltd.2$45
Otsuka Pharmaceutical Development & Commercialization, Inc.1$44
Sunovion Pharmaceuticals Inc.3$27
Jazz Pharmaceuticals Inc.1$24
Otsuka America Pharmaceutical, Inc.1$21
TG Therapeutics, Inc.1$21
Johnson & Johnson1$20
Impel Pharmaceuticals Inc.1$18
Immedica Pharma US, Inc.1$18
NS Pharma, Inc.1$17
Xeris Pharmaceuticals, Inc.1$16
Cala Health, Inc.1$15
Sanofi1$15
Acadia Pharmaceuticals Inc1$15
GE HealthCare1$14
MDD US Operations, LLC1$12

How this compares

$14,100 in reported general payments places this provider in the 95th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana →

Medicare billing

Part B allowed, 2024
$1,960
Medicare patients
11
Services billed
27

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Shreveport

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →